Deutsche Bank’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
LG
CFM
Deutsche Bank's CLPT Position: Q2 2026 in Review
Deutsche Bank reduced its ClearPoint Neuro (CLPT) stake by 50% in Q2 2026, selling an estimated $1.45M and leaving 114,795 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1895.
Deutsche Bank first reported a position in CLPT in Q2 2021 and has held it in 14 quarters since. The position peaked at $5.06M in Q3 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Deutsche Bank held 114,795 shares of ClearPoint Neuro worth $2.05M as of Q2 2026.
- Deutsche Bank sold 116,146 ClearPoint Neuro shares in Q2 2026, an estimated $1.45M.
- ClearPoint Neuro made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1895 holding.
- Deutsche Bank first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 14 quarters since.
- Deutsche Bank's ClearPoint Neuro position peaked at $5.06M in Q3 2025.
- 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.